Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization.
Nakano K, Ishiguro T, Konishi H, Tanaka M, Sugimoto M, Sugo I, Igawa T, Tsunoda H, Kinoshita Y, Habu K, Orita T, Tsuchiya M, Hattori K, Yamada-Okabe H.
Nakano K, et al. Among authors: tanaka m.
Anticancer Drugs. 2010 Nov;21(10):907-16. doi: 10.1097/CAD.0b013e32833f5d68.
Anticancer Drugs. 2010.
PMID: 20847643